![Emmanuel Coeytaux](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emmanuel Coeytaux
Net worth: 449 789 $ as of 30/05/2024
Profile
Dr. Emmanuel Coeytaux was previously employed as an EVP, Strategy & COO by DRI Capital, Inc. and a President by Steba Biotech NV.
He received his graduate degree from Ecole Polytechnique.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
DRI HEALTHCARE TRUST
0.07% | 24/10/2023 | 41,417 ( 0.07% ) | 449 789 $ | 30/05/2024 |
Former positions of Emmanuel Coeytaux
Companies | Position | End |
---|---|---|
Steba Biotech NV
![]() Steba Biotech NV Pharmaceuticals: MajorHealth Technology Steba Biotech NV is a Dutch company that manufactures cancer drugs. The CEO of the private company is Yehoshua Shemer. | President | 31/01/2021 |
DRI Capital, Inc.
![]() DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Chief Operating Officer | - |
Training of Emmanuel Coeytaux
Ecole Polytechnique | Graduate Degree |
Experiences
Positions held
Linked companies
Private companies | 2 |
---|---|
DRI Capital, Inc.
![]() DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Finance |
Steba Biotech NV
![]() Steba Biotech NV Pharmaceuticals: MajorHealth Technology Steba Biotech NV is a Dutch company that manufactures cancer drugs. The CEO of the private company is Yehoshua Shemer. | Health Technology |
- Stock Market
- Insiders
- Emmanuel Coeytaux